-
1
-
-
0025776117
-
Predictors of fractures in early rheumatoid arthritis
-
Michel BA, Bloch DA, Fries JF. Predictors of fractures in early rheumatoid arthritis. J Rheumatol 1991;18:804-8.
-
(1991)
J Rheumatol
, vol.18
, pp. 804-808
-
-
Michel, B.A.1
Bloch, D.A.2
Fries, J.F.3
-
2
-
-
0027131929
-
Fractures in rheumatoid arthritis: An evaluation of associated risk factors
-
Michel BA, Bloch DA, Wolfe F, Fries JF. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol 1993;20:1666-9.
-
(1993)
J Rheumatol
, vol.20
, pp. 1666-1669
-
-
Michel, B.A.1
Bloch, D.A.2
Wolfe, F.3
Fries, J.F.4
-
3
-
-
0028175451
-
Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis)
-
Scharla SH, Minne HW, Lempert UG, et al. Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis). Exp Clin Endocrinol 1994;102:44-9.
-
(1994)
Exp Clin Endocrinol
, vol.102
, pp. 44-49
-
-
Scharla, S.H.1
Minne, H.W.2
Lempert, U.G.3
-
4
-
-
0034066384
-
Guidelines for osteoporosis in celiac disease and inflammatory bowel disease
-
Scott EM, Gaywood I, Scott BB, for the British Society of Gastroenterology. Guidelines for osteoporosis in celiac disease and inflammatory bowel disease. Gut 2000;46 Suppl 1:I1-I8.
-
(2000)
Gut
, vol.46
, Issue.SUPPL. 1
-
-
Scott, E.M.1
Gaywood, I.2
Scott, B.B.3
-
5
-
-
1642526641
-
RANK Signaling is not required for TNF alpha-mediated increase in CD11bhi osteoclast precursors but is essential for mature osteoclast formation in TNF-alpha-mediated inflammatory arthritis
-
Li P, Schwarz EM, O'Keefe RJ, Ma L, Boyce BF, Xing L. RANK Signaling is not required for TNF alpha-mediated increase in CD11bhi osteoclast precursors but is essential for mature osteoclast formation in TNF-alpha-mediated inflammatory arthritis. J Bone Miner Res 2004;19:207-13.
-
(2004)
J Bone Miner Res
, vol.19
, pp. 207-213
-
-
Li, P.1
Schwarz, E.M.2
O'Keefe, R.J.3
Ma, L.4
Boyce, B.F.5
Xing, L.6
-
6
-
-
0242409906
-
Tumor necrosis factor-alpha: Molecular and cellular mechanisms in skeletal pathology
-
Nanes MS. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 2003;321:1-15.
-
(2003)
Gene
, vol.321
, pp. 1-15
-
-
Nanes, M.S.1
-
7
-
-
0141528518
-
Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1-receptor
-
Abbas S, Zhang YH, Clohisy JC, Abu-Amer Y. Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1-receptor. Cytokine 2003;22:33-41.
-
(2003)
Cytokine
, vol.22
, pp. 33-41
-
-
Abbas, S.1
Zhang, Y.H.2
Clohisy, J.C.3
Abu-Amer, Y.4
-
8
-
-
0031857492
-
TNF-alpha increases expression of 1L-6 and ICAM-1 genes through activation of NF-kappa-B in osteoblast-like ROS17/2.8 cells
-
Kurokouchi K, Kambe F, Yasukawa KK. TNF-alpha increases expression of 1L-6 and ICAM-1 genes through activation of NF-kappa-B in osteoblast-like ROS17/2.8 cells. J Bone Miner Res 1998;13:1290-9.
-
(1998)
J Bone Miner Res
, vol.13
, pp. 1290-1299
-
-
Kurokouchi, K.1
Kambe, F.2
Yasukawa, K.K.3
-
9
-
-
0032748843
-
Relationship between soluble markers of immune activation and bone turnover in post-menopausal women with rheumatoid arthritis
-
Oelzner P, Franke S, Müller A, Hein G, Stein G. Relationship between soluble markers of immune activation and bone turnover in post-menopausal women with rheumatoid arthritis. Rheumatology Oxford 1999;38:841-7.
-
(1999)
Rheumatology Oxford
, vol.38
, pp. 841-847
-
-
Oelzner, P.1
Franke, S.2
Müller, A.3
Hein, G.4
Stein, G.5
-
10
-
-
5044224519
-
Downregulation by nuclear factor kappa-B of human 25-hydroxyvitamin D3 1-hydroxylase promoter-1
-
Ebert R, Jovanovic M, Ulmer M, et al. Downregulation by nuclear factor kappa-B of human 25-hydroxyvitamin D3 1-hydroxylase promoter-1. Mol Endocrinol 2004;18:2440-50.
-
(2004)
Mol Endocrinol
, vol.18
, pp. 2440-2450
-
-
Ebert, R.1
Jovanovic, M.2
Ulmer, M.3
-
11
-
-
0345486982
-
Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis
-
Oelzner P, Muller A, Deschner F, et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 1998;62:193-8.
-
(1998)
Calcif Tissue Int
, vol.62
, pp. 193-198
-
-
Oelzner, P.1
Muller, A.2
Deschner, F.3
-
12
-
-
0031761970
-
Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: Association with immunological hyperactivity and only minor changes in calcium homeostasis
-
Haug CJ, Aukrust P, Haug E, Morkrid L, Muller F, Froland SS. Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab 1998;83:3832-8.
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 3832-3838
-
-
Haug, C.J.1
Aukrust, P.2
Haug, E.3
Morkrid, L.4
Muller, F.5
Froland, S.S.6
-
13
-
-
0018390550
-
Intestinal calcium-binding protein and calcium absorption in cortisol-treated chicks. Effect of vitamin D3 and 1,25-dihydroxyvitamin D3
-
Feher JJ, Wasserman RH. Intestinal calcium-binding protein and calcium absorption in cortisol-treated chicks. Effect of vitamin D3 and 1,25-dihydroxyvitamin D3. Endocrinology 1979;104:547-51.
-
(1979)
Endocrinology
, vol.104
, pp. 547-551
-
-
Feher, J.J.1
Wasserman, R.H.2
-
14
-
-
0036307222
-
Mechanisms of glucocorticoid action in bone
-
Canalis E, Delany AM. Mechanisms of glucocorticoid action in bone. Ann NY Acad Sci 2002;966:73-81.
-
(2002)
Ann NY Acad Sci
, vol.966
, pp. 73-81
-
-
Canalis, E.1
Delany, A.M.2
-
15
-
-
0032528180
-
Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone
-
Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998;102:274-282.
-
(1998)
J Clin Invest
, vol.102
, pp. 274-282
-
-
Weinstein, R.S.1
Jilka, R.L.2
Parfitt, A.M.3
Manolagas, S.C.4
-
17
-
-
0024547167
-
Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1
-
Flores EA, Bistrian BR, Pomposelli J, Dinarello CA, Blackburn GL, Istfan NW. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1. J Clin Invest 1989;83:1614-22.
-
(1989)
J Clin Invest
, vol.83
, pp. 1614-1622
-
-
Flores, E.A.1
Bistrian, B.R.2
Pomposelli, J.3
Dinarello, C.A.4
Blackburn, G.L.5
Istfan, N.W.6
-
18
-
-
0034523428
-
The divergent effects of tumour necrosis factor-alpha on skeletal muscle: Implications in wasting
-
Argiles JM, Alvarez B, Carbo N, Busquets S, Van Royen M, Lopez-Soriano FJ. The divergent effects of tumour necrosis factor-alpha on skeletal muscle: implications in wasting. Eur Cytokine Netw 2000;11:552-9.
-
(2000)
Eur Cytokine Netw
, vol.11
, pp. 552-559
-
-
Argiles, J.M.1
Alvarez, B.2
Carbo, N.3
Busquets, S.4
Van Royen, M.5
Lopez-Soriano, F.J.6
-
19
-
-
0041802726
-
Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression
-
Ma K, Mallidis C, Bhasin S, et al. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab 2003;285:E363-71.
-
(2003)
Am J Physiol Endocrinol Metab
, vol.285
-
-
Ma, K.1
Mallidis, C.2
Bhasin, S.3
-
20
-
-
0032924566
-
Acute treatment with corticosteroids decreases IGF-1 and IGF-2 expression in the rat diaphragm and gastrocnemius
-
Gayan-Ramirez G, Vanderhoydone F, Verhoeven G, Decramer M. Acute treatment with corticosteroids decreases IGF-1 and IGF-2 expression in the rat diaphragm and gastrocnemius. Am J Respir Crit Care Med 1999;159:283-9.
-
(1999)
Am J Respir Crit Care Med
, vol.159
, pp. 283-289
-
-
Gayan-Ramirez, G.1
Vanderhoydone, F.2
Verhoeven, G.3
Decramer, M.4
-
21
-
-
0036203972
-
Reasons for the degeneration of ageing skeletal muscle: A central role for IGF-1 signalling
-
Grounds MD. Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling. Biogerontology 2002;3:19-24.
-
(2002)
Biogerontology
, vol.3
, pp. 19-24
-
-
Grounds, M.D.1
-
22
-
-
0026556605
-
Glucocorticoids decrease vitamin D receptor number and gene expression in human osteosarcoma cells
-
Godschalk M, Levy JR, Downs RW Jr. Glucocorticoids decrease vitamin D receptor number and gene expression in human osteosarcoma cells. J Bone Miner Res 1992;7:21-7.
-
(1992)
J Bone Miner Res
, vol.7
, pp. 21-27
-
-
Godschalk, M.1
Levy, J.R.2
Downs Jr., R.W.3
-
23
-
-
0028609449
-
Steroid hormone modulation of vitamin D receptor levels in human MG-63 osteosarcoma cells
-
Mahonen A, Maenpaa PH. Steroid hormone modulation of vitamin D receptor levels in human MG-63 osteosarcoma cells. Biochem Biophys Res Commun 1994;205:1179-86.
-
(1994)
Biochem Biophys Res Commun
, vol.205
, pp. 1179-1186
-
-
Mahonen, A.1
Maenpaa, P.H.2
-
24
-
-
0037469717
-
Benefits beyond the bones - Vitamin D against falls, cancer, hypertension and autoimmune diseases
-
Barthel HR, Scharla SH. Benefits beyond the bones - vitamin D against falls, cancer, hypertension and autoimmune diseases [German]. Dtsch Med Wochenschr 2003;128:440-6.
-
(2003)
Dtsch Med Wochenschr
, vol.128
, pp. 440-446
-
-
Barthel, H.R.1
Scharla, S.H.2
-
25
-
-
0025840269
-
1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor 1 (IGF-I) and IGF-binding protein-4 in mouse osteoblasts
-
Scharla SH, Strong DD, Mohan S, Baylink DJ, Linkhart TA. 1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor 1 (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Endocrinology 1991;129:3139-46.
-
(1991)
Endocrinology
, vol.129
, pp. 3139-3146
-
-
Scharla, S.H.1
Strong, D.D.2
Mohan, S.3
Baylink, D.J.4
Linkhart, T.A.5
-
26
-
-
0032578611
-
Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines
-
Hofbauer LC, Dunstan CR, Speisberg TC, Riggs BL, Khosla S. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. Biochem Biophys Res Commun 1998;250:776-81.
-
(1998)
Biochem Biophys Res Commun
, vol.250
, pp. 776-781
-
-
Hofbauer, L.C.1
Dunstan, C.R.2
Speisberg, T.C.3
Riggs, B.L.4
Khosla, S.5
-
27
-
-
0035204814
-
Vitamin D. Its role and uses in immunology
-
DeLuca HF, Cantorna MT. Vitamin D. Its role and uses in immunology. FASEB J 2001;15:2579-85.
-
(2001)
FASEB J
, vol.15
, pp. 2579-2585
-
-
DeLuca, H.F.1
Cantorna, M.T.2
-
28
-
-
0036220629
-
The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents
-
Mathieu C, Adorini L. The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents. Trends Mol Med 2002;8:174-9.
-
(2002)
Trends Mol Med
, vol.8
, pp. 174-179
-
-
Mathieu, C.1
Adorini, L.2
-
29
-
-
24944479306
-
Regulation of NF-kB activity leads to the down-regulation of TNF alpha expression caused by 1,25(OH)2D3 and 1,24(S)(OH)2D2 in inflammatory cells
-
Shany S, Cohen-Lahav M, Chaimovitz C, Douvdevani A. Regulation of NF-kB activity leads to the down-regulation of TNF alpha expression caused by 1,25(OH)2D3 and 1,24(S)(OH)2D2 in inflammatory cells. In: DeLuca symposium on vitamin D 2002:24.
-
(2002)
DeLuca Symposium on Vitamin D
, pp. 24
-
-
Shany, S.1
Cohen-Lahav, M.2
Chaimovitz, C.3
Douvdevani, A.4
-
30
-
-
0022972788
-
Dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells
-
Costa EM, Blau HM, Feldman D. Dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology 1986;119:2214-20.
-
(1986)
Endocrinology
, vol.119
, pp. 2214-2220
-
-
Costa, E.M.1
Blau, H.M.2
Feldman, D.3
-
31
-
-
0018626346
-
Myopathy in bone loss of ageing: Improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium
-
Sorensen OH, Lund BI, Saltin B, et al. Myopathy in bone loss of ageing: Improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci 1979;56:157-61.
-
(1979)
Clin Sci
, vol.56
, pp. 157-161
-
-
Sorensen, O.H.1
Lund, B.I.2
Saltin, B.3
-
32
-
-
0021248263
-
Inflammation-mediated osteopenia in the rat: A new animal model for pathological loss of bone mass
-
Minne HW, Pfeilschifter J, Scharla S, et al. Inflammation-mediated osteopenia in the rat: A new animal model for pathological loss of bone mass. Endocrinology 1984;115:50-4.
-
(1984)
Endocrinology
, vol.115
, pp. 50-54
-
-
Minne, H.W.1
Pfeilschifter, J.2
Scharla, S.3
-
33
-
-
0025884971
-
Inflammation-mediated osteopenia (IMO): No change in bone resorption during its development
-
Lempert UG, Minne HW, Fleisch H, Mühlbauer RC, Scharla SH, Ziegler R. Inflammation-mediated osteopenia (IMO): No change in bone resorption during its development. Calcif Tissue Int 1991;48:291-2.
-
(1991)
Calcif Tissue Int
, vol.48
, pp. 291-292
-
-
Lempert, U.G.1
Minne, H.W.2
Fleisch, H.3
Mühlbauer, R.C.4
Scharla, S.H.5
Ziegler, R.6
-
34
-
-
0004920352
-
Exclusion of autonomous 1,25(OH)2 vitamin D3 (calcitriol) formation as a pathogenetic principle of inflammation-mediated osteopenia (IMO)
-
Scharla S, Schmidt-Gayk H, Sattar P. Exclusion of autonomous 1,25(OH)2 vitamin D3 (calcitriol) formation as a pathogenetic principle of inflammation-mediated osteopenia (IMO). Acta Endocrinol 1984;105 Suppl 264:7.
-
(1984)
Acta Endocrinol
, vol.105
, Issue.SUPPL. 264
, pp. 7
-
-
Scharla, S.1
Schmidt-Gayk, H.2
Sattar, P.3
-
35
-
-
0024469580
-
1,25-Dihydroxyvitamin D3 prevents the decrease of bone mineral appositional rate in rats with inflammation-mediated osteopenia (IMO)
-
Lempert UG, Minne HW, Albrecht B, Scharla SH, Matthes F, Ziegler R. 1,25-dihydroxyvitamin D3 prevents the decrease of bone mineral appositional rate in rats with inflammation-mediated osteopenia (IMO). Bone Miner 1989;7:149-58.
-
(1989)
Bone Miner
, vol.7
, pp. 149-158
-
-
Lempert, U.G.1
Minne, H.W.2
Albrecht, B.3
Scharla, S.H.4
Matthes, F.5
Ziegler, R.6
-
36
-
-
0033050332
-
Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis
-
Reginster JY, Kuntz D, Verdickt W, et al. Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis. Osteoporos Int 1999;9:75-81.
-
(1999)
Osteoporos Int
, vol.9
, pp. 75-81
-
-
Reginster, J.Y.1
Kuntz, D.2
Verdickt, W.3
-
37
-
-
0345329614
-
Treatment of glucocorticoid-induced osteoporosis with alfacalcidol/calcium versus vitamin D/calcium
-
Ringe JD, Cöster A, Meng T, Schacht E, Umbach R. Treatment of glucocorticoid-induced osteoporosis with alfacalcidol/calcium versus vitamin D/calcium. Calcif Tissue Int 1999;65:337-40.
-
(1999)
Calcif Tissue Int
, vol.65
, pp. 337-340
-
-
Ringe, J.D.1
Cöster, A.2
Meng, T.3
Schacht, E.4
Umbach, R.5
-
38
-
-
4043111605
-
Pleiotropic effects of alfacalcidol in elderly patients with rheumatoid arthritis
-
Scharla SH, Schacht E, Bawey S, Kamilli I, Holle D, Lempert UG. Pleiotropic effects of alfacalcidol in elderly patients with rheumatoid arthritis. arthritis+rheuma 2003;23:268-74.
-
(2003)
Arthritis+rheuma
, vol.23
, pp. 268-274
-
-
Scharla, S.H.1
Schacht, E.2
Bawey, S.3
Kamilli, I.4
Holle, D.5
Lempert, U.G.6
-
39
-
-
0034020119
-
Vitamin D metabolites in rheumatoid arthritis: Findings - hypotheses - consequences
-
Hein G, Oelzner P. Vitamin D metabolites in rheumatoid arthritis: findings - hypotheses - consequences [German]. Z Rheumatol 2000;59 Suppl 1:28-32.
-
(2000)
Z Rheumatol
, vol.59
, Issue.SUPPL. 1
, pp. 28-32
-
-
Hein, G.1
Oelzner, P.2
-
40
-
-
1242291908
-
A home-based two-year strength training period in early rheumatoid arthritis led to good long-term compliance: A five year follow up
-
Hakkinen A, Sokka T, Hannonen P. A home-based two-year strength training period in early rheumatoid arthritis led to good long-term compliance: a five year follow up. Arthritis Rheum 2004;51:56-62.
-
(2004)
Arthritis Rheum
, vol.51
, pp. 56-62
-
-
Hakkinen, A.1
Sokka, T.2
Hannonen, P.3
-
41
-
-
1642320904
-
Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis
-
Ringe JD, Dorst A, Faber H, Schacht E, Rahlfs VW. Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis. Rheumatol Int 2004;24:63-70.
-
(2004)
Rheumatol Int
, vol.24
, pp. 63-70
-
-
Ringe, J.D.1
Dorst, A.2
Faber, H.3
Schacht, E.4
Rahlfs, V.W.5
|